Banner

Neuroscience Antibodies And Assays Global Market Report 2023 – By Product (Consumables, Instruments), By Technology (Molecular Diagnostics, Clinical Chemistry, Immunoassays Or Immunochemistry, Others Technologies), By Application (In Vitro Diagnostics, Research, Drug Discovery), By End User (Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies) – Market Size, Trends, And Global Forecast 2023-2032 

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | SKU CODE : | Delivery Time: 2-3 business days | Format :


The neuroscience antibodies & assays are used to study the development, systems, structure and function, disorders, and degeneration of the nervous system. Neuroscience is the study of the nervous system, its working, and diseases related to the nervous system. Antibodies and assays is a medical test that is based on principles of interaction between antigenic epitopes and antibodies, and this test is useful in neuroscience and the study of neurological disorders.

The main types of neuroscience antibodies & assays market products are consumables, and instruments. Consumables are used in many neurological studies and research experiments. Consumable includes assay kits, reagents, and antibodies that enable quantitative and real-time live-cell analysis. The technologies used are molecular diagnostics, clinical chemistry, immunoassays or immunochemistry, and other technologies. The various applications are in vitro diagnostics, research, and drug discovery. The various end users are hospitals and diagnostics centers, academic and research institutes, pharmaceutical and biotechnology companies.

The neuroscience antibodies & assays market research report is one of a series of new reports from The Business Research Company that provides neuroscience antibodies & assays market statistics, including neuroscience antibodies & assays industry global market size, regional shares, competitors with an neuroscience antibodies & assays market share, detailed neuroscience antibodies & assays market segments, market trends and opportunities, and any further data you may need to thrive in the neuroscience antibodies & assays industry. This neuroscience antibodies & assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global neuroscience antibodies & assays market size grew from $3.6 billion in 2022 to $4.04 billion in 2023 at a compound annual growth rate (CAGR) of 12.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The neuroscience antibodies & assays market size is expected to grow to $6.24 billion in 2027 at a CAGR of 11.5%.

The increase in incidents of neurological illnesses across the globe are expected to propel the growth of the neuroscience antibodies & assays market going forward. Neurological illnesses are disorders and affecting the nervous system, and examples of neurological disorders include epilepsy, Alzheimer’s disease, dementia, and so on. The rise in the number of neurological illnesses requires more research and development activities for the treatment of these diseases. Antibodies and assays are used in research and development activities to study development, systems, structure and function, and disorders and degeneration of the nervous system. Thus, the neuroscience antibodies & assays market grows with the increase in incidents of neurological illnesses. For instance, According to the World Health Organization, a Switzerland-based health promotion agency 55 million people live with dementia globally, and there are nearly 10 million new cases every year as per 2021 data. According to Alzheimer's Association a US based Non-profit association, 6.5 million people in the US have Alzheimer's disease as per 2022 data. As a result, the increased incidence of neurological illnesses across the world is driving the neuroscience antibodies and assays market forward.

Technological advancements are a key trend gaining popularity in the neuroscience antibodies and assays market. Major companies operating in the market are introducing new technologies such as Cisbio HTRF® that works on TR-FRET technology to sustain their position in the market. For instance, in October 2020, PerkinElmer Inc., a US-based diagnostics, life sciences, and environmental research company, launched ‘PerkinElmer Cisbio HTRF® Phospho-Ubiquitin (Ser65) Cellular Kit’. The new kit has applications in various disease areas such as Alzheimer’s and Parkinson’s disease. The novel assays can be applied to increase study specificity for the Phospho-Ubiquitin (Ser65) intersection point. With the help of TR-FRET technology helps to identify crucial mitophagy dysfunction and breakdowns in the intricate network between neurons and glial cells that can result in neurodegenerative disease.

In June 2022, Fujirebio, a Japanese multinational biotechnology company, acquired ADx NeuroSciences for an undisclosed amount. With this acquisition, Fujirebio will be able to provide neurodegenerative disease diagnostic solutions at the global level. ADx Neurosciences is a Belgium-based developer of neurodegenerative biomarkers and specialized in developing tailor-made antibodies and assays for pharma and in vitro diagnostics companies.

Major players in the neuroscience antibodies & assays market are Abcam PLC, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, GenScript Biotech Corporation, Merck KGaA, Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Siemens Healthineers, Tecan Group Ltd., Thermo Fisher Scientific Inc., and Enzo Life Sciences AG.

North America was the largest region in the neuroscience antibodies & assays market in 2022.  The regions covered in neuroscience antibodies & assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the neuroscience antibodies & assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The neuroscience antibodies & assays market consists of sales of antibodies and assay kits and reagents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global neuroscience antibodies and assays market is segmented -

1) By Product: Consumables, Instruments

2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunoassays Or Immunochemistry, Others Technologies

3) By Application: In Vitro Diagnostics, Research, Drug Discovery

4) By End User: Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies

    Table Of Contents

    1. Executive Summary

    2. Neuroscience Antibodies & Assays Market Characteristics

    3. Neuroscience Antibodies & Assays Market Trends And Strategies

    4. Neuroscience Antibodies & Assays Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Neuroscience Antibodies & Assays Market

    4.2. Ukraine-Russia War Impact On Neuroscience Antibodies & Assays Market

    4.3. Impact Of High Inflation On Neuroscience Antibodies & Assays Market

    5. Neuroscience Antibodies & Assays Market Size And Growth

    5.1. Global Neuroscience Antibodies & Assays Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Neuroscience Antibodies & Assays Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Neuroscience Antibodies & Assays Market Segmentation

    6.1. Global Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Consumables

    Instruments

    6.2. Global Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Molecular Diagnostics

    Clinical Chemistry

    Immunoassays Or Immunochemistry

    Others Technologies

    6.3. Global Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    In Vitro Diagnostics

    Research

    Drug Discovery

    6.4. Global Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospitals And Diagnostics Centers

    Academic And Research Institutes

    Pharmaceutical And Technology Companies

    7. Neuroscience Antibodies & Assays Market Regional And Country Analysis

    7.1. Global Neuroscience Antibodies & Assays Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Neuroscience Antibodies & Assays Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Neuroscience Antibodies & Assays Market  

    8.1. Asia-Pacific Neuroscience Antibodies & Assays Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Neuroscience Antibodies & Assays Market  

    9.1. China Neuroscience Antibodies & Assays Market Overview  

    9.2. China Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Neuroscience Antibodies & Assays Market  

    10.1. India Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Neuroscience Antibodies & Assays Market  

    11.1. Japan Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Neuroscience Antibodies & Assays Market  

    12.1. Australia Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Neuroscience Antibodies & Assays Market  

    13.1. Indonesia Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Neuroscience Antibodies & Assays Market  

    14.1. South Korea Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Neuroscience Antibodies & Assays Market  

    15.1. Western Europe Neuroscience Antibodies & Assays Market Overview

    15.2. Western Europe Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Neuroscience Antibodies & Assays Market  

    16.1. UK Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Neuroscience Antibodies & Assays Market  

    17.1. Germany Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Neuroscience Antibodies & Assays Market  

    18.4. France Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Neuroscience Antibodies & Assays Market  

    19.1. Eastern Europe Neuroscience Antibodies & Assays Market Overview

    19.2. Eastern Europe Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Neuroscience Antibodies & Assays Market  

    20.1. Russia Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Neuroscience Antibodies & Assays Market  

    21.1. North America Neuroscience Antibodies & Assays Market Overview

    21.2. North America Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Neuroscience Antibodies & Assays Market  

    22.1. USA Neuroscience Antibodies & Assays Market Overview

    22.2. USA Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Neuroscience Antibodies & Assays Market  

    23.1. South America Neuroscience Antibodies & Assays Market Overview

    23.2. South America Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Neuroscience Antibodies & Assays Market  

    24.1. Brazil Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Neuroscience Antibodies & Assays Market  

    25.1. Middle East Neuroscience Antibodies & Assays Market Overview

    25.2. Middle East Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Neuroscience Antibodies & Assays Market  

    26.1. Africa Neuroscience Antibodies & Assays Market Overview

    26.2. Africa Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Neuroscience Antibodies & Assays Market Competitive Landscape And Company Profiles

    27.1. Neuroscience Antibodies & Assays Market Competitive Landscape

    27.2. Neuroscience Antibodies & Assays Market Company Profiles

    27.2.1. Abcam PLC

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. BioLegend Inc.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Bio-Rad Laboratories Inc.

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Cell Signaling Technology Inc.

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. F. Hoffmann-La Roche AG

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Neuroscience Antibodies & Assays Market

    29. Neuroscience Antibodies & Assays Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Neuroscience Antibodies & Assays Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Global Neuroscience Antibodies & Assays Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: Asia-Pacific, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: China, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: India, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Japan, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Australia, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Indonesia, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: South Korea, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Western Europe, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: UK, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: Germany, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: France, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Eastern Europe, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: Russia, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: North America, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: USA, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: South America, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Brazil, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Middle East, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Africa, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 47: Abcam PLC Financial Performance
  • Table 48: BioLegend Inc. Financial Performance
  • Table 49: Bio-Rad Laboratories Inc. Financial Performance
  • Table 50: Cell Signaling Technology Inc. Financial Performance
  • Table 51: F. Hoffmann-La Roche AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Neuroscience Antibodies & Assays Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Global Neuroscience Antibodies & Assays Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: Asia-Pacific, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: China, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: India, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Japan, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Australia, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Indonesia, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: South Korea, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Western Europe, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: UK, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: Germany, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: France, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Eastern Europe, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: Russia, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: North America, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: USA, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: South America, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Brazil, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Middle East, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Africa, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 47: Abcam PLC Financial Performance
  • Figure 48: BioLegend Inc. Financial Performance
  • Figure 49: Bio-Rad Laboratories Inc. Financial Performance
  • Figure 50: Cell Signaling Technology Inc. Financial Performance
  • Figure 51: F. Hoffmann-La Roche AG Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report